If PAP is diagnosed during immunosuppressive treatment, physicians should consider that immunosuppressive treatment may exacerbate PAP and titrate immunosuppressive drugs regardless of KL-6 levels if other findings show an improvement in IP. The gene discussed is MUC1; the disease is incontinentia pigmenti.